Analisa D. Thompson

1.3k total citations
17 papers, 800 citations indexed

About

Analisa D. Thompson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Surgery. According to data from OpenAlex, Analisa D. Thompson has authored 17 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Analisa D. Thompson's work include Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (9 papers) and Ion channel regulation and function (2 papers). Analisa D. Thompson is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (9 papers) and Ion channel regulation and function (2 papers). Analisa D. Thompson collaborates with scholars based in United States, Australia and France. Analisa D. Thompson's co-authors include Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender, Zixiu Xiang, Satyawan Jadhav, J. Scott Daniels, Thomas M. Bridges, C. David Weaver and Patrick R. Gentry and has published in prestigious journals such as The FASEB Journal, Pain and Journal of Controlled Release.

In The Last Decade

Analisa D. Thompson

16 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Analisa D. Thompson United States	12	619	479	98	62	62	17	800
Jens Nagel Germany	18	490 0.8×	328 0.7×	104 1.1×	110 1.8×	77 1.2×	33	805
Kristoffer Sahlholm Sweden	19	501 0.8×	609 1.3×	50 0.5×	35 0.6×	47 0.8×	49	853
Jonathan W. Dickerson United States	15	419 0.7×	370 0.8×	87 0.9×	73 1.2×	30 0.5×	29	644
Ning-Sheng Cai United States	15	485 0.8×	415 0.9×	82 0.8×	93 1.5×	39 0.6×	21	759
Hong‐Jin Shu United States	16	548 0.9×	458 1.0×	33 0.3×	97 1.6×	87 1.4×	27	916
В. Е. Гмиро Russia	14	650 1.1×	569 1.2×	29 0.3×	77 1.2×	36 0.6×	97	814
Zaiga Bleuel Switzerland	8	350 0.6×	226 0.5×	64 0.7×	57 0.9×	72 1.2×	8	455
Helena Domin Poland	19	427 0.7×	304 0.6×	67 0.7×	46 0.7×	103 1.7×	42	819
Amanda Taylor United States	18	504 0.8×	490 1.0×	19 0.2×	83 1.3×	52 0.8×	29	866
Verònica Casadó-Anguera Spain	13	317 0.5×	347 0.7×	85 0.9×	69 1.1×	29 0.5×	22	592

Countries citing papers authored by Analisa D. Thompson

Since Specialization

Citations

This map shows the geographic impact of Analisa D. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Analisa D. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Analisa D. Thompson more than expected).

Fields of papers citing papers by Analisa D. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Analisa D. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Analisa D. Thompson. The network helps show where Analisa D. Thompson may publish in the future.

Co-authorship network of co-authors of Analisa D. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Analisa D. Thompson. A scholar is included among the top collaborators of Analisa D. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Analisa D. Thompson. Analisa D. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Spearing, Paul K., Sichen Chang, Analisa D. Thompson, et al.. (2025). Discovery of a Novel sp³-Rich M₁ Positive Allosteric Modulators (PAMs) Chemotype via Scaffold Hopping. ACS Medicinal Chemistry Letters. 16(7). 1231–1238.

Chang, Sichen, Analisa D. Thompson, Aidong Qi, et al.. (2023). Development of Potent and Selective Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 2 for the Potential Treatment of Alzheimer’s Disease. Alzheimer s & Dementia. 19(S21). 2 indexed citations

Gogliotti, Rocco D., Darren W. Engers, Pedro M. García-Barrantes, et al.. (2016). Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 26(12). 2915–2919. 3 indexed citations

Nickols, Hilary Highfield, Karen J. Gregory, Shaun R. Stauffer, et al.. (2015). VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. Journal of Pharmacology and Experimental Therapeutics. 356(1). 123–136. 28 indexed citations

Iderberg, Hanna, Analisa D. Thompson, Michael Bubser, et al.. (2015). Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology. 95. 121–129. 42 indexed citations

Engers, Julie L., Alice L. Rodriguez, Leah C. Konkol, et al.. (2015). Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents. Journal of Medicinal Chemistry. 58(18). 7485–7500. 55 indexed citations

Gould, Robert W., Michael Bubser, Max E. Joffe, et al.. (2015). Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects. Neuropsychopharmacology. 41(4). 1166–1178. 36 indexed citations

Nedelcovych, Michael T., Robert W. Gould, Andrew S. Felts, et al.. (2015). Selective Antagonism of mGlu5 Alters Sleep‐wake and Spectral EEG and Ameliorates Behavioral Abnormalities in a Rodent Model of Traumatic Stress. The FASEB Journal. 29(S1). 1 indexed citations

Nance, Kellie D., Patrick R. Gentry, Emily Days, et al.. (2014). Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM). Journal of Medicinal Chemistry. 57(23). 10192–10197. 36 indexed citations

10.

Xie, Xinmin, John T. Brogan, M. Schulte, et al.. (2013). Scaffold Hopping Affords a Highly Selective in vitro and in vivo T-Type Calcium Inhibitor Probe Free From IP Issues. 3 indexed citations

11.

Jones, Carrie K., Darren W. Engers, Analisa D. Thompson, et al.. (2011). Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄) with Oral Efficacy in an Antiparkinsonian Animal Model. Journal of Medicinal Chemistry. 54(21). 7639–7647. 50 indexed citations

12.

Jones, Carrie K., Michael Bubser, Analisa D. Thompson, et al.. (2011). The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 340(2). 404–421. 81 indexed citations

13.

Xiang, Zixiu, Analisa D. Thompson, Carrie K. Jones, Craig W. Lindsley, & P. Jeffrey Conn. (2011). Roles of the M1 Muscarinic Acetylcholine Receptor Subtype in the Regulation of Basal Ganglia Function and Implications for the Treatment of Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 340(3). 595–603. 57 indexed citations

14.

Nag, Subodh, et al.. (2010). Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia. Pain. 151(3). 806–815. 52 indexed citations

15.

Young, C.S., et al.. (2009). Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with AugmentTM Bone Graft or GEM 21S beta-tricalcium phosphate (β-TCP). Journal of Controlled Release. 140(3). 250–255. 31 indexed citations

16.

Brady, Ashley E., Carrie K. Jones, Thomas M. Bridges, et al.. (2008). Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats. Journal of Pharmacology and Experimental Therapeutics. 327(3). 941–953. 162 indexed citations

17.

Niswender, Colleen M., Kari A. Johnson, C. David Weaver, et al.. (2008). Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4. Molecular Pharmacology. 74(5). 1345–1358. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact